Idexx Laboratories | IDXX - Gross Profit On Sales

Stock Price
545.79
Daily Change
17.00 3.21%
Monthly
-6.39%
Yearly
4.62%
Q2 Forecast
518.16

Idexx Laboratories reported $722.74M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Accuray USD 41.89M 7.42M Dec/2024
Align Technology USD 736.59M 53M Mar/2026
AngioDynamics USD 44.78M 2.93M Sep/2025
Dentsply International USD 427M 16M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Fujifilm JPY 376.67B 29.16B Mar/2026
Globus Medical USD 496.26M 39.69M Mar/2026
Henry Schein USD 1.07B 7M Mar/2026
Idexx Laboratories USD 722.74M 64.62M Mar/2026
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
Masimo USD 250.8M 3.5M Mar/2026
Neogen USD 99M 7.7M Dec/2025
Orthofix International USD 153.28M 4.76M Dec/2025
Phibro Animal Health USD 133.5M 12.6M Dec/2025
ResMed USD 890.98M 12.26M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.43M 21K Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Zoetis USD 1.62B 20M Mar/2026